[1] 侯清涛, 李芸, 李舍予.全球糖尿病疾病负担现状[J].中国糖尿病杂志, 2016, 24(1):92. doi: 10.3969/j.issn.1006-6187.2016.01.023
[2] 何春秀, 郝桂荣, 张会君, 等.老年2型糖尿病患者医学应对方式及影响因素研究[J].中国全科医学, 2015, 15(5):525. doi: 10.3969/j.issn.1007-9572.2015.05.010
[3] 张霞.2型糖尿病的临床发病机制分析[J].齐齐哈尔医学院学报, 2013, 34(18):2673. doi: 10.3969/j.issn.1002-1256.2013.18.013
[4] 张黎明, 高凌.炎症细胞因子在2型糖尿病发病机制中的研究进展[J].重庆医学, 2016, 45(8):1113. doi: 10.3969/j.issn.1671-8348.2016.08.038
[5] 刘琼, 何翠英, 卫家芬.DPP-4抑制剂治疗2型糖尿病的研究进展及临床应用[J].实用药物与临床, 2015, 18(7):856.
[6] 廖涌.中国糖尿病的流行病学现状及展望[J].重庆医科大学学报, 2015, 40(7):1042.
[7] DEACON CF, HOLST JJ.Dipptidyl peptidase 4 inhibitors:a promising new therapeutic approach for the management of type 2 diabetes[J].Int J biochem Cell Bio, 2006, 38(5/6):831.
[8] AMORI RE, LAU J, PITTAS AG.Efficacy and safety of incretin therapy in type 2 diabetes:systematic review and meta-analysis[J].JAMA, 2007, 298:194. doi: 10.1001/jama.298.2.194
[9] ILKOVA H, GLASER B, TUNÇKALE A, et al.Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment[J].Diabetes Care, 1997, 20(9):1353. doi: 10.2337/diacare.20.9.1353
[10] HOTAMISLIGIL GS.Inflammatory pathways and insulin action[J].Int J Obes Relat Metab Disord, 2003, 27(Suppl)3:S53.[1] HEIDARI J, MIERSWA T, HASENBRING M, et al.Low back pain in athletes and non-athletes:a group comparison of basic pain parameters and impact on sports activity[J].Sport Sci Health, 2016, 12(3):1. doi: 10.1038/sj.ijo.0802502